methylguanidine has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WT; Chang, YL; Chen, HW; Chen, TJ; Chien, CT; Hsu, SM; Lee, YT; Liou, SY; Wang, TD | 1 |
| Nakagawa, S; Ozawa, K | 1 |
1 trial(s) available for methylguanidine and Hyperlipemia
| Article | Year |
|---|---|
Ascorbate supplement reduces oxidative stress in dyslipidemic patients undergoing apheresis.
Topics: Adult; Antioxidants; Ascorbic Acid; Biomarkers; C-Reactive Protein; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipid Peroxidation; Luminescent Measurements; Male; Malondialdehyde; Methylguanidine; Middle Aged; Neutrophils; Oxidative Stress; Plasmapheresis; Reactive Oxygen Species; Respiratory Burst; Treatment Outcome; Tyrosine; Uremia; Vitamin E | 2004 |
1 other study(ies) available for methylguanidine and Hyperlipemia
| Article | Year |
|---|---|
Protective aspects for atherogenesis and lipid abnormalities in continuous ambulatory peritoneal dialysis patients.
Topics: Aged; Aged, 80 and over; Arteriosclerosis; Creatinine; Female; Glutathione Peroxidase; Humans; Hyperlipidemias; Lipoprotein(a); Male; Malondialdehyde; Methylguanidine; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Probucol; Risk Factors; Selenium; Superoxide Dismutase | 1993 |